Hematocrit was not validated as a surrogate end point for survival among epoetin-treated hemodialysis patientsDennis J Cotter
Medical Technology and Practice Patterns Institute, Inc, 4733 Bethesda Avenue, Suite 510, Bethesda, MD 20814, USA
J Clin Epidemiol 57:1086-95. 2004
..To evaluate the use of hematocrit as a surrogate end point for survival among end-stage renal disease (ESRD) patients treated with epoetin...
- Translating epoetin research into practice: the role of government and the use of scientific evidence
Dennis Cotter
Medical Technology and Practice Patterns Institute Inc, Bethesda, Maryland, USA
Health Aff (Millwood) 25:1249-59. 2006
..Were the right choices made? Epoetin showcases the risk and benefit conundrum created when evidentiary standards are relaxed. Our review concludes with broad-based policy recommendations for the newly implemented Medicare Part D program...
- The effect of epoetin dose on hematocrit
D Cotter
Medical Technology and Practice Patterns Institute, 4733 Bethesda Avenue, Suite 510, Bethesda, Maryland 20814, USA
Kidney Int 73:347-53. 2008
....
Estimated effect of epoetin dosage on survival among elderly hemodialysis patients in the United StatesYi Zhang
Medical Technology and Practice Patterns Institute, Bethesda, Maryland 20814, USA
Clin J Am Soc Nephrol 4:638-44. 2009
....
- Factors influencing route of administration for epoetin treatment among hemodialysis patients in the United States
Mae Thamer
Medical Technology and Practice Patterns Institute, Bethesda, MD, USA
Am J Kidney Dis 48:77-87. 2006
..Given the similar effectiveness, but significantly decreased dose associated with SC epoetin, these findings suggest an enormous opportunity for cost savings for the Medicare program...
- Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis
Mae Thamer
Medical Technology and Practice Patterns Institute, Bethesda, MD 20814, USA
JAMA 297:1667-74. 2007
..The type of facility (profit, chain, and affiliation status) at which a patient receives dialysis might affect epoetin dosing patterns and has implications for future epoetin policies...
- Epoetin requirements predict mortality in hemodialysis patients
Yi Zhang
Medical Technology and Practice Patterns Institute, Bethesda, MD 20814, USA
Am J Kidney Dis 44:866-76. 2004
..Escalating epoetin doses often are used to overcome epoetin resistance. The objective of this study is to examine the relationship between epoetin dose requirements and mortality...
High doses of epoetin do not lower mortality and cardiovascular risk among elderly hemodialysis patients with diabetesYi Zhang
Medical Technology and Practice Patterns Institute, 4733 Bethesda Avenue, Bethesda, MD 20814, USA
Kidney Int 80:663-9. 2011
..Our findings support a Food and Drug Administration advisory recommending that the lowest possible ESA dose be used to treat hemodialysis patients...
- Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis: the authors respond
Mae Thamer
Medical Technology and Practice Patterns Institute, Bethesda, Maryland 20814, USA
Am J Kidney Dis 50:538-41. 2007
- The effect of dialysis chains on mortality among patients receiving hemodialysis
Yi Zhang
Medical Technology and Practice Patterns Institute, 4733 Bethesda Ave, Bethesda, MD 20814, USA
Health Serv Res 46:747-67. 2011
..To examine the association between dialysis facility chain affiliation and patient mortality...
- Prednisone, lupus activity, and permanent organ damage
Mae Thamer
Medical Technology and Practice Patterns Institute, Bethesda, MD 20814, USA
J Rheumatol 36:560-4. 2009
..To estimate the effect of corticosteroids (prednisone dose) on permanent organ damage among persons with systemic lupus erythematosus (SLE)...
